These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17558564)

  • 1. Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits.
    Siuciak JA; McCarthy SA; Martin AN; Chapin DS; Stock J; Nadeau DM; Kantesaria S; Bryce-Pritt D; McLean S
    Psychopharmacology (Berl); 2007 Oct; 194(2):185-95. PubMed ID: 17558564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.
    Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR
    Neuropharmacology; 2007 Jul; 53(1):113-24. PubMed ID: 17559891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance in neurokinin 3 receptor knockout mice.
    Nordquist RE; Delenclos M; Ballard TM; Savignac H; Pauly-Evers M; Ozmen L; Spooren W
    Psychopharmacology (Berl); 2008 Jun; 198(2):211-20. PubMed ID: 18351324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice.
    Hou Y; Wu CF; Yang JY; Guo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1486-95. PubMed ID: 16842896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice.
    Nordquist RE; Savignac H; Pauly-Evers M; Walker G; Knoflach F; Borroni E; Glaentzlin P; Bohrmann B; Messer J; Ozmen L; Albientz A; Spooren W
    Behav Pharmacol; 2008 Sep; 19(5-6):518-29. PubMed ID: 18690106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinin NK3-receptor deficiency does not inhibit pulmonary eosinophilia in allergic mice.
    Kung TT; Crawley Y; Jones H; Luo B; Gilchrest H; Greenfeder S; Anthes JC; Lira S; Wiekowski M; Cook DN; Hey JA; Egan RW; Chapman RW
    Pharmacol Res; 2004 Dec; 50(6):611-5. PubMed ID: 15501700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys.
    De Souza Silva MA; Mello EL; Müller CP; Jocham G; Maior RS; Huston JP; Tomaz C; Barros M
    Eur J Pharmacol; 2006 May; 536(3):269-78. PubMed ID: 16603151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning.
    Senechal Y; Kelly PH; Dev KK
    Behav Brain Res; 2008 Jan; 186(1):126-32. PubMed ID: 17884188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism.
    de Souza Silva MA; Lenz B; Rotter A; Biermann T; Peters O; Ramirez A; Jessen F; Maier W; Hüll M; Schröder J; Frölich L; Teipel S; Gruber O; Kornhuber J; Huston JP; Müller CP; Schäble S
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15097-102. PubMed ID: 23983264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
    Qiao J; Zhang Q; Li M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():177-85. PubMed ID: 24140929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.
    Siuciak JA; McCarthy SA; Chapin DS; Martin AN
    Psychopharmacology (Berl); 2008 Mar; 197(1):115-26. PubMed ID: 18060387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pregabalin on fear-based conditioned avoidance learning and spatial learning in a mouse model of scopolamine-induced amnesia.
    Sałat K; Podkowa A; Malikowska N; Trajer J
    Toxicol Mech Methods; 2017 Mar; 27(3):181-190. PubMed ID: 27996351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.
    Watt ML; Rorick-Kehn L; Shaw DB; Knitowski KM; Quets AT; Chesterfield AK; McKinzie DL; Felder CC
    Neuropsychopharmacology; 2013 Dec; 38(13):2717-26. PubMed ID: 23907402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-specific knockout of FE65 leads to impaired learning and memory.
    Wang B; Hu Q; Hearn MG; Shimizu K; Ware CB; Liggitt DH; Jin LW; Cool BH; Storm DR; Martin GM
    J Neurosci Res; 2004 Jan; 75(1):12-24. PubMed ID: 14689444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function.
    Siuciak JA; McCarthy SA; Chapin DS; Fujiwara RA; James LC; Williams RD; Stock JL; McNeish JD; Strick CA; Menniti FS; Schmidt CJ
    Neuropharmacology; 2006 Aug; 51(2):374-85. PubMed ID: 16769090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired striatum-dependent behavior in GASP-1-knock-out mice.
    Mathis C; Bott JB; Candusso MP; Simonin F; Cassel JC
    Genes Brain Behav; 2011 Apr; 10(3):299-308. PubMed ID: 21091868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further identification of neurokinin receptor types and mechanisms of calcium signaling evoked by neurokinins in the murine neuroblastoma C1300 cell line.
    Fukuhara S; Mukai H; Kako K; Nakayama K; Munekata E
    J Neurochem; 1996 Sep; 67(3):1282-92. PubMed ID: 8752137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice.
    Hebb AL; Robertson HA; Denovan-Wright EM
    Eur Neuropsychopharmacol; 2008 May; 18(5):339-63. PubMed ID: 17913473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.
    Ortega-Alvaro A; Aracil-Fernández A; García-Gutiérrez MS; Navarrete F; Manzanares J
    Neuropsychopharmacology; 2011 Jun; 36(7):1489-504. PubMed ID: 21430651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.